Cargando…
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
Autores principales: | Farmer, Ruth E, Ford, Deborah, Forbes, Harriet J, Chaturvedi, Nishi, Kaplan, Richard, Smeeth, Liam, Bhaskaran, Krishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837431/ https://www.ncbi.nlm.nih.gov/pubmed/28419306 http://dx.doi.org/10.1093/ije/dyx046 |
Ejemplares similares
-
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
por: Farmer, Ruth E, et al.
Publicado: (2017) -
Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models
por: Farmer, Ruth E, et al.
Publicado: (2019) -
Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
por: Brauer, Ruth, et al.
Publicado: (2015) -
Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006–2019: A cohort study
por: Eastwood, Sophie V., et al.
Publicado: (2021) -
A systematic review and meta-analysis of risk factors for postherpetic neuralgia
por: Forbes, Harriet J., et al.
Publicado: (2016)